Funding for this research was provided by:
Russian Science Foundation (16-15-10426)
Text and Data Mining valid from 2019-01-23
Received: 3 October 2018
Revised: 16 January 2019
Accepted: 17 January 2019
First Online: 23 January 2019
Compliance with ethical standards
: The authors declare that they have no potential conflicts of interests. The authors have applied for patents concerning the use of Cas9 proteins and gRNAs for HBV therapy.
: This work was supported by RSF Grant no. 16-15-10426.